Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
NINGBO INNO PHARMCHEM CO.,LTD. is proud to highlight the emerging role of (+)-Cloprostenol isopropyl ester in the field of ophthalmic research. While widely recognized for its veterinary applications, this synthetic prostaglandin analog is gaining attention for its potential as an ocular hypotensive agent, a key characteristic for managing conditions like glaucoma.
Glaucoma is a group of eye diseases that damage the optic nerve, often caused by abnormally high pressure in the eye. Reducing intraocular pressure (IOP) is the primary goal in managing this condition. Research indicates that (+)-Cloprostenol isopropyl ester, as a potent prostaglandin F2α (PGF2α) agonist, can effectively lower IOP. This activity is attributed to its interaction with FP receptors in the eye, which influences the outflow of aqueous humor, thereby reducing pressure. The compound's structural similarity to naturally occurring prostaglandins allows it to mimic their physiological effects, albeit with enhanced potency and duration.
The exploration of (+)-Cloprostenol isopropyl ester in ophthalmic research is building upon the known effects of other prostaglandin analogs used clinically for glaucoma treatment. Studies are investigating its efficacy, safety profile, and optimal delivery methods for ophthalmic applications. As a synthetic prostaglandin F2α analog, its precise chemical properties and predictable biological responses make it an attractive candidate for further preclinical and clinical investigations. The availability of this compound for research purposes supports the ongoing development of novel therapies for visual impairments.
Furthermore, the compound's role as a pharmaceutical intermediate also extends to the potential development of new ocular drugs. By understanding the structure-activity relationship of such prostaglandin derivatives, researchers can design more targeted and effective treatments. The precise identification of cloprostenol isopropyl ester CAS 157283-66-4 is crucial for ensuring the reproducibility and validity of these scientific endeavors. Researchers seeking to explore these possibilities can rely on NINGBO INNO PHARMCHEM CO.,LTD. for access to this critical research material.
The ongoing research into (+)-Cloprostenol isopropyl ester's ophthalmic potential signifies a promising avenue for innovation in eye care. As studies progress, this compound may well contribute to new therapeutic strategies for patients suffering from elevated intraocular pressure and related conditions.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
